Michael Eichbaum

Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer

Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Surgery

Cancer Invasion and the Microenvironment: Plasticity and Reciprocity

Natural products: A continuing source of novel drug leads

The selectin–selectin ligand axis in tumor progression

Modulation of oxidative stress as an anticancer strategy

Tumor Metastasis: Molecular Insights and Evolving Paradigms

CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Surgeon Volume and Operative Mortality in the United States

Tumor Dynamics in Response to Antiangiogenic Therapy with Oral Metronomic Topotecan and Pazopanib in Neuroblastoma Xenografts

Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates

Emerging Biological Principles of Metastasis

Cancer and Radiation Therapy: Current Advances and Future Directions

The role of local therapy in the management of lung and liver oligometastases

The present and future role of microfluidics in biomedical research

Strategies and challenges for the next generation of antibody–drug conjugates

Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes

CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

Cancer-related inflammation and treatment effectiveness

Crossing the endothelial barrier during metastasis

Sexually Transmitted Infections Treatment Guidelines, 2021

Bendamustine: Rebirth of an Old Drug

Discovery of O-Alkylamino-Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer Agents

Epithelial Mesenchymal Transition in Tumor Metastasis

Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release

Advances and Advantages of Nanomedicine in the Pharmacological Targeting of Hyaluronan-CD44 Interactions and Signaling in Cancer

Surgeon volume and operative mortality in the United States

Association of Surgical Specialty and Processes of Care With Patient Outcomes for Carotid Endarterectomy

Combination therapy in combating cancer

2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors

Multi-targeted therapy of cancer by niclosamide: A new application for an old drug

Drug Resistance in Cancer: An Overview

The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer

Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol

Liver Resection for Multimodal Treatment of Breast Cancer Metastases: Identification of Prognostic Factors

Grading of Internal Carotid Artery Stenosis: Validation of Doppler/Duplex Ultrasound Criteria and Angiography Against Endarterectomy Specimen

Prognostic factors for patients with liver metastases from breast cancer

Acceptance of oral chemotherapy in breast cancer patients - a survey study

Value and feasibility of LLETZ procedures for pregnant women with suspected high‐grade squamous intraepithelial lesions and microinvasive cervical cancer

Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study

Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study

Breast cancer cell-derived cytokines, macrophages and cell adhesion: implications for metastasis.

Serum Levels of Soluble E-Selectin Are Associated With the Clinical Course of Metastatic Disease in Patients With Liver Metastases From Breast Cancer

In vitro blockade of adhesion of breast cancer cells to endothelial cells using anti-inflammatory drugs.